Omeros reported $439.82M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Cytokinetics CYTK:US USD 609.73M 411.31M
Insmed INSM:US USD 807.48M 366K
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Knight Therapeutics Inc GUD:CN CAD 11.62M 239K
Omeros OMER:US USD 439.82M 125.46M
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Rockwell Medical RMTI:US USD 8.96M 1.41M
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M